Aggressiveness of inflammation in histological prostatitis - Correlation with total and free prostate specific antigen levels in men with biochemical criteria for prostate biopsy

Scottish Medical Journal

Volumn 54, Issue 3, 2009, Pages 8-12

  Stimac, Goran ^a   Reljic, A ^a   Spajic, B ^a   Dimanovski, J ^a   Ruzic, B ^a   Ulamec, M ^a   Sonicki, Z ^b   Kraus, O ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Free prostate specific antigen; Prostate biopsy; Prostate cancer; Prostate inflammation; Prostate specific antigen; Prostatitis

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGE; AGED; ARTICLE; BIOPSY; BLOOD; CANCER INVASION; COHORT ANALYSIS; HUMAN; MALE; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PREDICTION AND FORECASTING; PROSTATE TUMOR; PROSTATITIS; RETROSPECTIVE STUDY; RISK FACTOR;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; ORGAN SIZE; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROSTATITIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 70350499751     PISSN: 00369330     EISSN: None     Source Type: Journal    
DOI: 10.1258/RSMSMJ.54.3.8     Document Type: Article

References (26)

1. Benson MC, Whang LS, Olsson CA. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 1992; 147: 817-821
2. Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994; 151: 1283-1290
3. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991; 145: 907-911
4. Irani J, Levillain P, Goujon JM, Bon D, Dore B, Aubert J. Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value. J Urol 1997; 157(4): 1301-1303 (Pubitemid 27130803)
5. Catalona WJ. Clinical utility of measurements of free and total prostate-specific antigen (PSA): a review. Prostate Suppl 1996; 7: 64.
6. Blumenfeld W, Tucci S, Narayan P. Incidental lymphocytic prostatitis. Selective involvement with nonmalignant glands. Am J Surg Pathol 1992; 16(10): 975-981
7. Kohnen PW, Drach GW. Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study. J Urol 1979; 121(6): 755-760
8. Ornstein DK, Smith DS, Humphrey P, Catalona W. The effect of prostate volume, age, total prostate specific antigen level and acute inflammation on the percentage of free serum specific antigen in men without clinically detectable prostate cancer. J Urol 1998; 159: 1234-1237 (Pubitemid 28172804)
9. Morote J, Lopez M, Encabo G, Tores IM. Effect of inflammation and benign prostatic hyperplasia on total and percent free serum prostate specific antigen. Eur Urol 2000; 37: 537-540 (Pubitemid 30189821)
10. Jung K, Meyer A, Lein M, Rudolph B, Schnorr D, Loening S. Ratio of free to total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate. J Urol 1998; 159: 1595-1598 (Pubitemid 29117348)
11. Meyer A, Jung K, Lein M, Rudolph B, Schnorr D, Loening SA. Factors influencing the ratio of free to total prostate-specific antigen in serum. Int J Cancer 1997; 74(6): 630-636 (Pubitemid 28037507)
12. Minardi D, Galosi AB, Recchioni A. Diagnostic accuracy of percent free PSA in prostatic pathology and its usefelness in monitoring prostate cancer patients. Urol Int 2001; 67: 272-282 (Pubitemid 33153209)
13. Scattoni V, Raber M, Montrosi F, et al. Percent of free serum prostate specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia. Eur Urol 1999; 36: 621-630 (Pubitemid 29516294)
14. Catalona WJ, Richie JP, deKernion JB, et al. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. J Urol 1994; 152(6 Pt 1): 2031-2036
15. Kwak C, Ku JH, Kim T, et al. Effect of subclinical prostatic inflammation on serum PSA levels in men with clinically undetectable prostate cancer. Urology 2003; 62: 854-859 (Pubitemid 37421231)
16. Brawer MK, Rennels MA, Nagle RB, Schifman R, Gaines JA. Serum prostate-specific antigen and prostate pathology in men having simple prostatectomy. Am J Clin Pathol 1989; 92(6): 760-764 (Pubitemid 20007640)
17. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 1995; 154: 407-413
18. Hasui Y, Marutsuka K, Asada Y, Ide H, Nishi S, Osada Y. Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate 1994; 25: 91-99
19. Okada K, Kojima M, Naya Y, et al. Correlation of histological inflammation in needle biopsy specimens with serum prostate specific antigen levels in men with negative biopsy for prostate cancer. Urology 2000; 55: 892-898 (Pubitemid 30330795)
20. Nickel JC, Downey J, Young I. Asymptomatic inflammation and/or infection in benign prostatic hyperplasia. Bju Int 1999; 84: 976.
21. Ozden C, Ozdal OL, Guzel O, Han O, Seckin S, Memis A. The correlation between serum prostate specific antigen levels and asymptomatic inflammatory prostatitis. Int Urol Nephrol 2006 Nov 17; (Epub ahead of print)
22. Hoekx L, Jeuris W, Van Marck E, Wyndaele JJ. Elevated serum prostate specific antigen (PSA) related to asymptomatic prostatic inflammation. Acta Urol Belg 1998;66(3):1-2.
23. Yaman O, Gogus C, Tulunay O, Tokatli Z, Ozden E. Increased prostate-specific antigen in subclinical prostatitis: the role of aggressiveness and extension of inflammation. Urol Int 2003; 71(2): 160-164 (Pubitemid 36928786)
24. Christensson A, Bjork T, Nilsson O. Serum prostate specific antigen complexed to alpha-1-antichymotrypsin as an indicator of prostate cancer. J Urol 1993; 150: 100-105 (Pubitemid 23175981)
25. Bjork T, Hulkko S, Bjartell A, di Sant Agnese A, Abrahamsson PA, Lilja H. Alpha 1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia. Urology 1994; 43: 427.
26. Zackrisson B, Ulleryd P, Aus G, Lilja H, Sandberg T, Hugosson J. Evolution of free, complexed, and total serum prostate-specific antigen and their ratios during 1 year of follow-up of men with febrile urinary tract infection. Urology 2003; 62(2): 278-281 (Pubitemid 36952077)